Safety and efficacy of belimumab in systemic lupus erythematosus academic clinical practices

OBJECTIVE: Belimumab (Benlysta) is a human monoclonal antibody that inhibits soluble B-lymphocyte stimulator and was approved by the FDA for treatment of adults with systemic lupus erythematosus (SLE). This study evaluates the use and efficacy of belimumab in academic SLE practices. METHODS: Invitat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Rheumatol
Autors principals: Hui-Yuen, Joyce S., Reddy, Arthi, Taylor, Jennifer, Li, Xiaoqing, Eichenfield, Andrew H., Bermudez, Liza M., Starr, Amy J., Imundo, Lisa F., Buyon, Jill, Furie, Richard A., Kamen, Diane L., Manzi, Susan, Petri, Michelle, Ramsey-Goldman, Rosalind, van Vollenhoven, Ronald F., Wallace, Daniel J., Askanase, Anca
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031077/
https://ncbi.nlm.nih.gov/pubmed/26523030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.150470
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars